Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period

• Status: Completed
• Trial end date: 2008-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this observational study is to examine RSI (Reflux Symptom Index) and RFS (Reflux Finding Score) by treatment period before and after rabeprazole treatment in LaryngoPharyngeal Reflux Disease(LPRD) patients.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Janssen Korea, Ltd., Korea
• Treatments: Rabeprazole

Criteria

Inclusion Criteria:

• Patients who visit the department of otolaryngology with suspicious laryngopharyngeal reflux

• Patients who need rabeprazole treatment according to the doctor's discretion

• Patients who have signed an informed consent document indicating that they understand the purpose of and procedures required for the observational study and they agree to provide their information

Exclusion Criteria:

• Patients who took rabeprazole within the past one month

• Patients who are hypersensitive to any of rabeprazole or benzimidazole

• Patients with severe hepatic impairment

• Pregnant or lactating women